Try Fund Library Premium
Free with a 30 day trial!
Gain access to
- Unlimited Watchlists
- Advanced Search Filtering
- Fund Comparisons
- Portfolio Scenarios
- Customizable PDF Reports
- Portfolio Rebalancer new
RBC Life Science and Technology Fund Series A
U.S. Equity
Click for more information on Fundata’s FundGrade
FundGrade A
Click for more information on Fundata’s FundGrade.
Click for more information on Fundata’s ESG Grade
Fundata ESG Grade B
Click for more information on Fundata’s ESG Grade.
FundGrade A+® Rating Recipient
2025, 2024, 2023, 2022, 2021
Click for more information on Fundata’s FundGrade
|
NAVPS (06-23-2026) |
$70.85 |
|---|---|
| Change |
-$1.39
(-1.93%)
|
As at May 31, 2026
As at April 30, 2026
As at May 31, 2026
Loading......
Legend
Compare Options
Fund Returns
Inception Return (July 31, 1995): 8.93%
| Row Heading | Return | Annualized Return | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 Mth | 3 Mth | 6 Mth | YTD | 1 Yr | 2 Yr | 3 Yr | 4 Yr | 5 Yr | 6 Yr | 7 Yr | 8 Yr | 9 Yr | 10 Yr | |
| Fund | 11.07% | 18.34% | 11.19% | 14.25% | 40.51% | 23.96% | 26.47% | 24.56% | 18.53% | 18.42% | 19.90% | 18.28% | 17.90% | 18.72% |
| Benchmark | 6.61% | 11.78% | 9.89% | 12.01% | 30.16% | 22.09% | 24.20% | 20.67% | 17.24% | 18.16% | 17.70% | 16.50% | 15.73% | 16.24% |
| Category Average | 5.39% | 8.95% | 7.75% | 9.30% | 23.05% | 16.04% | 18.97% | 15.39% | 11.84% | 14.12% | 13.39% | 12.21% | 11.82% | 12.19% |
| Category Rank | 50 / 1,401 | 94 / 1,391 | 215 / 1,376 | 175 / 1,379 | 68 / 1,320 | 93 / 1,247 | 118 / 1,187 | 42 / 1,136 | 32 / 1,073 | 61 / 1,014 | 25 / 951 | 25 / 882 | 32 / 826 | 26 / 749 |
| Quartile Ranking | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Monthly Return
| Return % | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan | Feb | Mar | Apr | May |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund | 6.66% | 4.52% | 0.49% | 7.08% | 5.83% | -0.45% | -2.68% | -0.92% | -2.56% | -3.88% | 10.84% | 11.07% |
| Benchmark | 4.21% | 3.75% | 1.28% | 5.00% | 3.05% | -0.03% | -1.89% | 0.38% | -0.17% | -2.91% | 8.00% | 6.61% |
Best Monthly Return Since Inception
37.88% (February 2000)
Worst Monthly Return Since Inception
-21.85% (February 2001)
Calendar Return (%)
| Return % | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Fund | -0.84% | 22.08% | 8.77% | 25.94% | 29.23% | 24.97% | -22.89% | 37.42% | 37.19% | 15.03% |
| Benchmark | 8.65% | 13.80% | 3.98% | 25.18% | 16.07% | 28.16% | -12.52% | 23.32% | 36.01% | 12.28% |
| Category Average | 6.16% | 13.43% | -2.19% | 22.72% | 13.97% | 23.22% | -14.41% | 18.85% | 26.98% | 8.65% |
| Quartile Ranking | 4 | 1 | 1 | 2 | 1 | 2 | 4 | 1 | 1 | 1 |
| Category Rank | 599/ 693 | 110/ 771 | 90/ 856 | 306/ 919 | 136/ 986 | 419/ 1,051 | 878/ 1,094 | 107/ 1,149 | 232/ 1,229 | 106/ 1,272 |
Best Calendar Return (Last 10 years)
37.42% (2023)
Worst Calendar Return (Last 10 years)
-22.89% (2022)
Asset Allocation
| Name | Percent |
|---|---|
| US Equity | 93.99 |
| International Equity | 3.97 |
| Cash and Equivalents | 1.40 |
| Canadian Equity | 0.64 |
Sector Allocation
| Name | Percent |
|---|---|
| Technology | 72.25 |
| Healthcare | 17.83 |
| Consumer Services | 3.20 |
| Industrial Goods | 1.95 |
| Cash and Cash Equivalent | 1.40 |
| Other | 3.37 |
Geographic Allocation
| Name | Percent |
|---|---|
| North America | 95.82 |
| Europe | 2.60 |
| Latin America | 0.73 |
| Asia | 0.63 |
| Other | 0.22 |
Top Holdings
| Name | Percent |
|---|---|
| Alphabet Inc Cl A | 10.82 |
| NVIDIA Corp | 10.39 |
| Apple Inc | 9.42 |
| Microsoft Corp | 7.98 |
| Broadcom Inc | 4.79 |
| Meta Platforms Inc Cl A | 4.73 |
| Eli Lilly and Co | 2.59 |
| Johnson & Johnson | 2.35 |
| Netflix Inc | 1.73 |
| Applied Materials Inc | 1.40 |
Equity Style
Fixed Income Style
Risk vs Return (3 Yr)
RBC Life Science and Technology Fund Series A
Median
Other - U.S. Equity
3 Yr Annualized
| Standard Deviation | 15.83% | 16.96% | 15.12% |
|---|---|---|---|
| Beta | 1.23 | 1.15 | 1.08 |
| Alpha | -0.03 | -0.01 | 0.01 |
| Rsquared | 0.87% | 0.87% | 0.84% |
| Sharpe | 1.35 | 0.92 | 1.09 |
| Sortino | 2.78 | 1.54 | 1.77 |
| Treynor | 0.17 | 0.14 | 0.15 |
| Tax Efficiency | 100.00% | 100.00% | 100.00% |
| Volatility |
|
|
|
Risk Rating
Annualized Key Ratio Period Comparison
| Key Ratio | 1 Yr | 3 Yr | 5 Yr | 10 Yr |
|---|---|---|---|---|
| Standard Deviation | 18.42% | 15.83% | 16.96% | 15.12% |
| Beta | 1.54 | 1.23 | 1.15 | 1.08 |
| Alpha | -0.06 | -0.03 | -0.01 | 0.01 |
| Rsquared | 0.96% | 0.87% | 0.87% | 0.84% |
| Sharpe | 1.83 | 1.35 | 0.92 | 1.09 |
| Sortino | 5.55 | 2.78 | 1.54 | 1.77 |
| Treynor | 0.22 | 0.17 | 0.14 | 0.15 |
| Tax Efficiency | 100.00% | 100.00% | 100.00% | 100.00% |
Fundata ESG Metrics
Fundata ESG Score
The E, S, and G scores are averaged for each security in the portfolio, to arrive at an ESG score for each security. We take the portfolio weighted average of the ESG scores for each fund and rank them against their peers to arrive at the Fundata ESG Score from 0-100.
Fundata E Score
Three scores under the Environment bucket are averaged to yield the Fundata Environment Score for each fund from 0-100: (1) Pollution Prevention, (2) Environmental Transparency, (3) Resource Efficiency.
Fundata S Score
Six scores under the Social bucket are averaged to yield the Fundata Social Score for each fund from 0-100. (1) Compensation and Satisfaction, (2) Diversity and Rights, (3) Education and Work Conditions, (4) Community and Charity, (5) Human Rights, (6) Sustainability Integration.
Fundata G Score
Three scores under the governance bucket are averaged to yield the Fundata Governance Score for each fund from 0-100: (1) Board Effectiveness, (2) Management Ethics, (3) Disclosure and Accountability.
Powered by OWL Analytics. For more information, please contact Fundata Canada.
Fund Details
| Start Date | July 31, 1995 |
|---|---|
| Instrument Type | Mutual Fund |
| Share Class | Commission Based Advice |
| Legal Status | Trust |
| Sales Status | Open |
| Currency | CAD |
| Distribution Frequency | Annual |
| Assets ($mil) | $3,289 |
Fund Codes
| FundServ Code | Load Code | Sales Status |
|---|---|---|
| RBF274 |
Investment Objectives
The objective of the fund is to provide long-term capital growth. The fund invests primarily in equity securities of U.S. companies whose businesses relate to life sciences and technology and are expected to benefit from scientific and technological advances.
Investment Strategy
The fund’s investment process is primarily based on fundamental research, although the portfolio manager will also consider quantitative and technical factors. Stock selection decisions are ultimately based on an understanding of the company, its business and its outlook. Life science investments include biotechnology, medical devices and services, pharmaceuticals and medical instruments.
Portfolio Management
| Portfolio Manager |
RBC Global Asset Management Inc.
|
|---|---|
| Sub-Advisor |
- |
Management and Organization
| Fund Manager |
RBC Global Asset Management Inc. |
|---|---|
| Custodian |
RBC Investor Services Trust (Canada) |
| Registrar |
RBC Global Asset Management Inc. Royal Bank of Canada RBC Investor Services Trust (Canada) |
| Distributor |
Royal Mutual Funds Inc. |
Investment Minimums
| RSP Eligible | Yes |
|---|---|
| PAC Allowed | Yes |
| PAC Initial Investment | 25 |
| PAC Subsequent | 25 |
| SWP Allowed | Yes |
| SWP Min Balance | 10,000 |
| SWP Min Withdrawal | 100 |
Fees
| MER | 2.05% |
|---|---|
| Management Fee | 1.75% |
| Load | No Load |
| FE Max | - |
| DSC Max | - |
| Trailer Fee Max (FE) | - |
| Trailer Fee Max (DSC) | - |
| Trailer Fee Max (NL) | 1.00% |
| Trailer Fee Max (LL) | - |
Try Fund Library Premium
Free with a 30 day trial!
Gain access to
- Unlimited Watchlists
- Advanced Search Filtering
- Fund Comparisons
- Portfolio Scenarios
- Customizable PDF Reports
- Portfolio Rebalancer new
